Different Skin Fungi Trigger Different Antimicrobial Peptides and Inflammatory Responses

Researchers exposed HaCaT human keratinocyte cells to three Malassezia species — M. restricta, M. globosa, and M. sympodialis — and then measured multiple immune outputs. They assessed NLRP3 inflammasome activation, IL-1β secretion, expression of pro-inflammatory cytokines (IL-8, IL-22) and chemokines (CCL17, CCL22) at the mRNA and protein level, and production of antimicrobial peptides including LL-37 and beta-defensin 2.

Malassezia is the most common fungus on human skin, yet its exact role in causing skin disease has been hard to pin down. By showing that different species trigger fundamentally different immune responses — including distinct antimicrobial peptide patterns — this study provides a molecular explanation for why Malassezia-associated conditions vary so much clinically. This could eventually guide species-specific treatment strategies.

The human skin's antimicrobial peptide defense system — including LL-37 and beta-defensins — is a first-line shield against pathogens. This study shows that these defenses are not generic; they are tuned to the specific microbial threat. Understanding how different fungi trigger different antimicrobial peptide responses could inform the development of targeted therapies for common skin conditions and deepen our understanding of how the skin's innate immune system distinguishes between microbial species.

This was an in vitro study using a single keratinocyte cell line (HaCaT), which does not capture the full complexity of intact skin with its multiple cell types, immune cells, and microbiome. Only three of the 14+ known Malassezia species were tested. The fungal concentrations used in the lab may not reflect natural skin colonization levels. No patient tissue or clinical correlation was included.